(Q73739015)
Statements
Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study (English)
P F Backeljauw
L E Underwood
GHIS Collaborative Group. Growth hormone insensitivity syndrome